Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Priority review status granted for Avakine

Feb. 26, 1998

Cell adhesion inhibitors from Yoshitomi

Feb. 26, 1998

Abbott reveals new motilides

Feb. 23, 1998

New gastrointestinal agents reported by Yoshitomi

Feb. 19, 1998

Enrollment complete for hepatitis C vaccine phase I trial

Feb. 19, 1998

Endorex licenses oral hepatitis B vaccine technology

Feb. 19, 1998

Bio-Technology General licenses hepatitis B vaccine

Feb. 17, 1998

JB-9315: a new H2 antagonist with both antisecretory and cytoprotective properties

Feb. 16, 1998

Plant extract DA-9601 protects against NSAID-induced gastric damage

Feb. 12, 1998

New agents for IBS from Nippon Shinyaku

Feb. 11, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...